RenNano® Mouse

RenNano® Mouse: Heavy chain only antibody (HCAb) & nanobody discovery platform


Key Features

Nanobody Platform Overview

Fully human HCAbs can be obtained directly from immunized RenNano® mice and developed into nanobodies or used as building blocks for other modalities.

1. Fully human heavy chain variable region and modified constant region


2. RenNano mice exhibit normal B cell development and differentiation

B cell development and differentiation patterns in RenNano® mice. RenNano mice have comparable B cell proportions in peripheral lymphoid organs (spleen, SP and lymph nodes, LN) to WT mice or RenMab mice. Spleens from RenNano mice also have comparable percentages of follicular B (FO-B) cells and marginal zone B (MZ-B) cells to WT mice or RenMab mice.

3. RenNano mice demonstrate robust immune responses against multiple antigens

RenNano mice’ immune responses against TFR1, 4-1BB, and ALB. Sera from RenNano® mice immunized with TFR-1 and 4-1BB (membrane antigens) were diluted and incubated with antigen-expressing CHO cells. Fluorochrome-conjugated secondary antibodies were used to label CHO-bound HCAbs, and mean fluorescence intensity (MFI) was measured using flow cytometry to indicate the antigen-specific HCAb titer. Sera from RenNano mice immunized with ALB (secreted antigen) were diluted and incubated with fluorochrome-conjugated secondary antibodies. OD450 was measured using ELISA to indicate the antigen-specific HCAb titer.

4. RenNano-derived antigen-specific HCAbs showed great diversity

HCAbs derived from RenNano mice are diverse and many contain longer CDR3 regions. Antigen-specific HCAbs were analyzed by their heavy chain germline gene usage and CDR3 length. Analysis indicates broad IGHV germline diversity. Additionally, most CDR3 lengths observed were longer than 12 AA, with some longer than 17 AA.

5.RenNano-derived HCAbs show high binding affinity

The affinity of 68 purified RenNano HCAbs for 8 targets (4-1BB, TROP2, IL3RA, OX40, Nectin-4, ROR1, PSMA and DLL3) were tested by SPR. For most HCAbs, KD were between 10-6 ~ 10-10 M.

6.RenNano-derived HCAbs demonstrate outstanding developability

RenNano HCAbs’ physiochemical property analysis. RenNano HCAbs show high purity after one-step purification (A). HCAbs exhibit short retention time in HIC-HPLC and CIC-HPLC, indicating superb hydrophilicity and specificity (B, C). RenNano HCAbs also exhibit favorable thermostability (D).